Comparison of PREDICTS atherosclerosis biomarker changes after initiation of new treatments in patients with SLE.

Maureen McMahonBrian SkaggsJennifer GrossmanWeng Kee WongLori SahakianWeiling ChenBevra Hahn

Published in: Lupus science & medicine (2019)

12 weeks of MMF therapy improves the overall PREDICTS atherosclerosis biomarker profile. Further studies will determine whether biomarker changes reflect decreases in future cardiovascular events.

Keyphrases

cardiovascular events
cardiovascular disease
coronary artery disease
systemic lupus erythematosus
type diabetes
stem cells
mesenchymal stem cells
disease activity
case control
cell therapy
gestational age
clinical evaluation